<DOC>
	<DOCNO>NCT02359604</DOCNO>
	<brief_summary>Proton Pump Inhibitors ( PPI ) standard therapy pediatric GERD . In past hypothesized , either direct inhibition bacterial ATPase elevation pH may lead change intestinal microbiome . Small series publish adult suggest predominance streptococci , possible reason increase incidence pneumonia PPI therapy . Studies child yet scarce . This study include 20 infant . GERD verify 24h-intraluminal impedance monitoring . All patient undergo conservative measure prior initiation PPI therapy ( due persisting symptom ) . Children receive commercial PPI 8 week ( esomeprazole 1mg/kg/day ) . Stool sample collect initiation PPI , PPI ( 4 week initiation ) 8 week discontinue PPI therapy . The intestinal microbiome determine 16S rDNA-based microbial community profile high-throughput pyrosequencing . Data compare dependent non parametric test ( Wilcoxon ) . P-values &lt; 0.05 consider statistically significant .</brief_summary>
	<brief_title>The Gastrointestinal Microbiome Infants With GERD PPI Therapy : Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>symptomatic GERD ( prove impedance monitoring ) despite conservative treatment require PPI therapy neurological impairment</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>1 Year</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>infant</keyword>
	<keyword>ppi</keyword>
	<keyword>proton pump inhibitor</keyword>
	<keyword>microbiome</keyword>
	<keyword>Microbiota</keyword>
</DOC>